# Wellmune (Beta-Glucan from Saccharomyces cerevisiae)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/wellmune
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-30
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Beta-1,3/1,6-D-glucan, Baker's yeast beta-glucan, Saccharomyces cerevisiae beta-glucan, Yeast-derived beta-glucan, Immunogenic yeast extract, Purified yeast cell wall extract, Beta-glucan WGP, Insoluble yeast beta-glucan

## Overview

Wellmune is a proprietary 1,3/1,6-[beta-glucan](/ingredients/condition/immune-support) derived from the cell wall of Saccharomyces cerevisiae yeast, standardized to activate innate immune cells via Dectin-1 and CR3 receptor binding. Clinical trials demonstrate it reduces upper respiratory tract infection incidence by up to 66% in children and shortens symptom duration in physically stressed adults.

## Health Benefits

• Reduces upper respiratory tract infection (URTI) incidence and duration by up to 66% in children (RCT evidence)
• Decreases cold/flu symptom days in marathon runners and stressed adults (multiple RCTs)
• Increases immune cell activation including monocytes, CD4+ T cells, and [cytokine](/ingredients/condition/inflammation) production (RCT evidence)
• Improves mood, vigor, and reduces fatigue during physical or psychological stress (RCT in 77 women)
• Enhances salivary IgA levels by 32% post-exercise, strengthening mucosal [immunity](/ingredients/condition/immune-support) (clinical study)

## Mechanism of Action

Wellmune's 1,3/1,6-[beta-glucan](/ingredients/condition/immune-support) polysaccharides are recognized by Dectin-1 receptors on macrophages and dendritic cells, triggering Syk-CARD9 signaling and downstream NF-κB activation, which upregulates [pro-inflammatory cytokine](/ingredients/condition/inflammation) production including IL-12, TNF-α, and IL-6. Phagocytized beta-glucan fragments are transported to bone marrow and peripheral lymphoid tissue, where they prime neutrophils and NK cells via complement receptor 3 (CR3/CD11b) priming without causing systemic inflammation. This priming effect increases the respiratory burst capacity of monocytes and elevates circulating CD4+ T-helper cell populations, enhancing adaptive immune readiness.

## Clinical Summary

Multiple randomized, double-blind, placebo-controlled trials support Wellmune's efficacy; a key pediatric RCT (n=174 children) demonstrated a 66% reduction in URTI incidence over a 12-week supplementation period at 75 mg/day. Studies in marathon runners (n=182) showed significant reductions in upper respiratory symptom days and severity scores in the two weeks post-race compared to placebo. A stressed adult cohort trial (n=77) reported fewer cold and flu symptom days and improved Global Vigor and Affect scores at 250 mg/day. Evidence quality is moderate-to-strong for acute [immune support](/ingredients/condition/immune-support) in stressed and physically active populations, though large-scale trials in healthy, non-stressed adults are more limited.

## Nutritional Profile

Wellmune is a purified, soluble beta-1,3/1,6-glucan polysaccharide derived from the cell wall of Saccharomyces cerevisiae (baker's yeast). It is not a significant source of macronutrients or micronutrients at typical dosing levels (250–500 mg/day). Primary bioactive compound: beta-1,3/1,6-D-glucan at >75% purity by dry weight, with the remainder consisting of trace proteins (<5%), minimal lipids (<1%), and residual moisture. No clinically meaningful quantities of vitamins or minerals are present at therapeutic doses. The beta-glucan backbone consists of a linear beta-1,3-linked glucose chain with beta-1,6-linked side branches, which is structurally distinct from oat or mushroom beta-glucans and is responsible for its [immunomodulatory](/ingredients/condition/immune-support) activity via CR3 (complement receptor 3) and Dectin-1 receptor binding on innate immune cells. Fiber content: Wellmune itself IS a soluble dietary fiber (non-digestible polysaccharide), contributing approximately 0.25 g fiber per 250 mg dose, though this is not its primary nutritional role. Bioavailability: Wellmune is not absorbed intact; it is phagocytosed by macrophages in the Peyer's patches of the gut, then transported and processed intracellularly, releasing fragments that prime neutrophils and monocytes — this is a receptor-mediated immunological mechanism rather than systemic absorption. Caloric contribution is negligible (<2 kcal per typical dose). No significant sugar, sodium, or fat content at standard dosing.

## Dosage & Preparation

Children (1-4 years): 35-75 mg daily. Adults: 250 mg daily for 4-13 weeks, particularly during periods of physical or psychological stress. Athletes: 250-500 mg daily post-exercise. Available as insoluble powder or dispersible/soluble formulations in beverages. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Wellmune is generally well-tolerated; no serious adverse events were reported across published RCTs at doses of 75–500 mg/day, with mild gastrointestinal discomfort noted rarely. Individuals on immunosuppressive medications such as cyclosporine, tacrolimus, or corticosteroids should consult a physician before use, as [beta-glucan](/ingredients/condition/immune-support)-driven immune activation could theoretically counteract immunosuppression. Those with autoimmune conditions including rheumatoid arthritis, lupus, or multiple sclerosis should exercise caution, as CR3 and Dectin-1 stimulation may aggravate disease activity. Safety data in pregnant or breastfeeding women is insufficient, and use during pregnancy should be deferred until further research is available.

## Scientific Research

Multiple randomized controlled trials support Wellmune's immune benefits, including studies in 154 children showing 66% reduction in cold incidence (Meng et al. 2016), 182 marathon runners with reduced cold/flu days (McFarlin et al. 2013), and 77 stressed women with fewer URTI symptoms (PMID: 23378458). Additional RCTs demonstrated reduced URTI severity post-marathon (PMID: 30380356) and differential effects of soluble vs. insoluble forms (PMID: 31573387).

## Historical & Cultural Context

No traditional or historical medicinal use was documented for Wellmune in the research. As a modern branded extract developed through proprietary processing, it lacks documented use in traditional medicine systems such as Ayurveda or Traditional Chinese Medicine.

## Synergistic Combinations

Vitamin C, Vitamin D3, Zinc, Elderberry, [Probiotic](/ingredients/condition/gut-health)s

## Frequently Asked Questions

### What is the recommended daily dose of Wellmune beta-glucan?

Clinical trials have used doses ranging from 75 mg/day in children to 250–500 mg/day in adults, with 250 mg/day being the most common adult dose demonstrating statistically significant immune benefits. Wellmune supplements typically provide a standardized extract containing at least 75% 1,3/1,6-beta-glucan by dry weight. Always follow the manufacturer's label, as concentration can vary between products.

### How long does it take for Wellmune to work?

Most RCTs observed measurable immune biomarker changes, including elevated monocyte activation and increased CD4+ T cell counts, within 2–4 weeks of daily supplementation. Clinical outcomes such as reduced URTI incidence were assessed over 12-week periods, suggesting consistent daily use is necessary for meaningful protection. Acute immune priming effects on neutrophils have been observed within hours of ingestion in ex vivo studies, but functional protection builds over weeks.

### Is Wellmune beta-glucan safe for children?

A well-designed pediatric RCT involving 174 children used 75 mg/day of Wellmune for 12 weeks with no serious adverse events reported and tolerability comparable to placebo. The study population included children aged 1–4 years, suggesting safety at this dose in young children under supervised conditions. Parents should consult a pediatrician before use, particularly in children with known immune conditions or those taking prescription medications.

### What is the difference between Wellmune and ordinary beta-glucan supplements?

Wellmune is a proprietary, highly purified 1,3/1,6-beta-glucan from Saccharomyces cerevisiae yeast, standardized for molecular weight and branching structure to ensure consistent Dectin-1 and CR3 receptor binding activity. Generic beta-glucan supplements may derive from oats (1,3/1,4-beta-glucan), mushrooms, or unstandardized yeast sources, which have different molecular structures and primarily affect cholesterol metabolism rather than innate immune priming. The specific 1,3/1,6-branching pattern in Wellmune is critical for its immune-activating mechanism and is what distinguishes it from oat-derived beta-glucan used for cardiovascular health.

### Can athletes or people under stress benefit more from Wellmune?

Yes; the strongest clinical evidence for Wellmune comes from physically and psychologically stressed populations. An RCT in 182 marathon runners showed significantly fewer upper respiratory symptom days and lower symptom severity scores during the two weeks following a race compared to placebo. A separate study in stressed adults (n=77) at 250 mg/day found improved Global Vigor and Affect scores alongside reduced cold and flu days, suggesting Wellmune is particularly beneficial when the immune system is compromised by physiological or psychological stressors.

### What clinical evidence supports Wellmune's effectiveness for immune health?

Wellmune has been studied in multiple randomized controlled trials (RCTs) demonstrating a 66% reduction in upper respiratory tract infection incidence and duration in children, and significant decreases in cold/flu symptom days in marathon runners and stressed adults. Research shows Wellmune activates key immune cells including monocytes and CD4+ T cells while increasing cytokine production, which are measurable markers of enhanced immune function. The evidence base distinguishes Wellmune from standard beta-glucan supplements through its specific particle size and processing that enhance bioavailability to immune receptors.

### Does Wellmune interact with common medications or vaccines?

Wellmune beta-glucan is derived from baker's yeast and works through natural immune cell activation pathways, making significant drug interactions unlikely with most common medications. However, individuals taking immunosuppressive medications (such as those following organ transplants) should consult their healthcare provider before use, as Wellmune enhances immune function which could theoretically counteract immunosuppression. There are no known contraindications with standard vaccines; in fact, Wellmune may support immune response, though timing should be discussed with a healthcare provider.

### Can I get equivalent immune support from eating baker's yeast or whole foods instead of Wellmune?

While baker's yeast naturally contains beta-glucans, Wellmune uses a proprietary extraction and processing method that concentrates and optimizes the beta-glucan particle size for specific immune receptor recognition—something you cannot achieve through diet alone. Whole food sources like nutritional yeast, mushrooms, and oats contain beta-glucans but in lower concentrations and with different structural configurations than the clinically-studied Wellmune formulation. The RCT evidence demonstrating Wellmune's efficacy is specifically tied to this branded ingredient's bioavailability profile rather than general dietary beta-glucan intake.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*